+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of the DT-diaphorase inhibitor dicumarol on striatal monoamine levels in L-DOPA and L-deprenyl pre-treated rats

Effects of the DT-diaphorase inhibitor dicumarol on striatal monoamine levels in L-DOPA and L-deprenyl pre-treated rats

Neurotoxicity Research 5(8): 569-577

It has been proposed that DT-diaphorase plays a strategic role as a neuroprotective enzyme for monoamine neurons, perhaps together with monoamine oxidase (MAO). Thus, we investigated the long-term effects produced by DT-diaphorase inhibition with dicumarol injected unilaterally into the medial forebrain bundle (MFB) on monoamine and metabolite levels, alone, or following dopamine loading with 3,4-dihydroxyphenyl-L-alanine (L-DOPA) or MAO inhibition with L-deprenyl. Monoamine levels were assayed in aliquots from tissue samples from right and left striatum, including both dorsal and ventral regions. Dicumarol alone produced increases in 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA), but not in dopamine and metabolite levels when assayed two weeks later. However, following preloading with L-DOPA (3 x 25 mg/kg s.c. 7, 4 and 1 h before surgery), a long-lasting bilateral increase in dopamine and metabolite levels was observed after dicumarol. No effect was observed on dopamine, 5-HT and metabolite levels after L-deprenyl (3 x 10 mg/kg, s.c.) alone, but the levels were unilaterally increased when L-deprenyl was followed by dicumarol. The same result was produced when both L-deprenyl and dicumarol were injected simultaneously into the same brain region. In conclusion, the present study shows that intracerebral inhibition of DT-diaphorase produces long-term changes in 5-HT, but also in dopamine metabolism when DT-diaphorase inhibition is combined with MAO inhibition by systemic or intracerebral treatment with L-deprenyl. It is suggested that both MAO and DT-diaphorase have to be inhibited for inducing long-term changes in monoamine metabolism. Thus, DT-diaphorase is an enzyme to be taken into account when L-DOPA is used to treat Parkinson's disease, or when an MAO-inhibitor is used to treat depression.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 048916143

Download citation: RISBibTeXText

PMID: 15111234

Related references

Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice. Journal of Neural Transmission 110(12): 1375-1391, 2003

Memantine, amantadine, and L-deprenyl potentiate the action of L-DOPA in monoamine-depleted rats. Journal Of Neural Transmission General Section. 98(1): 57-67, 1994

The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats. Journal of Neural Transmission 108(2): 189-204, 2001

Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-DOPA and dopamine in rats. European Journal Of Pharmacology. 273(3): 215-221, 1995

Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor. Pharmacology Biochemistry and Behavior 77(2): 245-251, 2004

Regional alterations in the monoamine levels, monoamine oxidase activity & neurobehavioural effects in rats treated with Dimecron (phosphamidon). Indian Journal of Medical Research 94: 71-75, 1991

Regional alterations in the monoamine levels monoamine oxidase activity and neurobehavioral effects in rats treated with dimecron phosphamidon. Indian Journal of Medical Research Section B 94(FEB): 71-75, 1991

Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA. Neuropharmacology 76 Pt A: 156-168, 2014

Influence of Selective Inhibition of Monoamine Oxidase A or B on Striatal Metabolism of L-DOPA in Hemiparkinsonian Rats. Journal Of Neurochemistry. 65(3): 1213-1220, 1995

Striatal dopamine, sexual activity and lifespan. Longevity of rats treated with (-)deprenyl. Life Sciences 45(6): 525-531, 1989

Striatal dopamine sexual activity and lifespan longevity of rats treated with levo deprenyl. Life Sciences 45(6): 525-532, 1989